bismuth has been researched along with ranitidine in 243 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (8.23) | 18.7374 |
| 1990's | 123 (50.62) | 18.2507 |
| 2000's | 92 (37.86) | 29.6817 |
| 2010's | 6 (2.47) | 24.3611 |
| 2020's | 2 (0.82) | 2.80 |
| Authors | Studies |
|---|---|
| Bär, W; Freise, J; Gebel, M; Gladziwa, U; Haruma, K; Lange, P; Schmidt, FW; Wagner, S | 1 |
| Corbishley, CM; Goggin, PM; Jackson, PA; Marrero, JM; Northfield, TC; Spychal, RT | 1 |
| Laine, L | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Saeed, ZA | 1 |
| Barnett, C; Peterson, WL; Yates, S | 1 |
| Fraser, A; Hudson, M; Nwokolo, CU; Pounder, RE; Prewett, EJ; Sawyerr, AM | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM | 1 |
| Hudson, M; Nwokolo, CU; Pounder, RE; Prewett, EJ; Sawyerr, AM | 1 |
| Annibale, B; Corleto, V; de Magistris, L; Delle Fave, G; Giordano, E; Puoti, M; Torsoli, A | 1 |
| Bayerdörffer, E; Mannes, GA; Pfaller, P; Sauerbruch, T | 1 |
| Bär, W; Freise, J; Fritsch, S; Schmidt, FW; Wagner, S | 1 |
| Hardman, M; Lee, FI; Samloff, IM | 1 |
| Misiewicz, JJ | 2 |
| McAdam, WA; Morgan, AG; Pacsoo, C; Taylor, P | 1 |
| Benfield, P; Monk, JP; Wagstaff, AJ | 1 |
| Bianchi Porro, G; Lazzaroni, M; Parente, F; Petrillo, M | 1 |
| Cowen, AE; Halliday, C; Ward, M | 1 |
| Barbara, L; Corinaldesi, R; Paternicò, A; Rea, E; Stanghellini, V | 1 |
| Deveney, CW; Deveney, KE | 1 |
| McAdam, WA; Morgan, AG; Pacsoo, C | 1 |
| Bazuro, G; Capurso, L; Fracasso, P; Koch, M; Luzietti, L; Palomba, M; Papi, C; Tarquini, M | 1 |
| Schubert, TT | 1 |
| Zimmerman, TW | 1 |
| Barr, GD; Piper, DW | 1 |
| Levine, JB | 1 |
| Bernier, JJ | 1 |
| Pounder, RE | 2 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Jablonská, M | 1 |
| Ciociola, AA; Goodwin, BB; Perschy, TB; Webb, DD | 1 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Müller, P; Simon, B | 1 |
| Frazer, NM; Keene, ON; Lacey, LF; Smith, JT | 1 |
| al-Assi, MT; Cole, RA; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
| Bedding, AW; Farr, SJ; Forster, ER; Parikh, R; Smith, JT; Sweetland, J | 1 |
| Cole, AT; Hawkey, CJ; Hudson, N; Lettis, S; Murray, FE; Turnbull, GM | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| Campbell, DR; Cherian, R; McGregor, DH; Weston, AP | 1 |
| al-Assi, MT; Genta, RM; Graham, DY; Lew, GM; Ramirez, FC | 1 |
| Börsch, G; Labenz, J | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Graham, DY; Hepps, KS; Lew, GM; Ramirez, FC; Saeed, ZA | 1 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 1 |
| Campbell, CJ; Clayton, NM; Clitherow, JW; Grinham, CJ; McColm, AA; McLaren, A; Stables, R; Trevethick, MA | 1 |
| Loffeld, RJ; Rutten, FF; Schipper, CK | 1 |
| Glassman, MS; Halata, MS; Rosioru, C; Schwarz, SM | 1 |
| Fraser, AG; Hudson, M; Lam, WM; Luk, YW; Pounder, RE; Samloff, IM; Sawyerr, AM; Sercombe, J | 1 |
| Fraser, AG; Lewin, JF; Pounder, RE | 1 |
| Bardhan, KD; Dekkers, CP; Forster, JK; Kler, L; Lacey, LF; Lam, SK; Nowak, A; Schaffalitzky de Muckadell, OB; Schutze, K; Tildesley, G | 1 |
| Bang, CJ; Berstad, A; Berstad, K; Hatlebakk, JG; Hausken, T; Hundal, O; Nesje, LB; Nysaeter, G; Olafsson, S; Tefera, S | 1 |
| Battaglia, G; Di Mario, F; Grasso, G; Leandro, G; Vianello, F; Vigneri, S | 1 |
| Jönsson, B | 1 |
| Caucheteur, B; De Koster, E; Deltenre, M; Jonas, C; Otero, J | 1 |
| Campbell, CJ; Connolly, PC; Francis, MR; Grinham, CJ; Klinkert, G; McColm, AA; McLaren, A; Selway, S; Williamson, R | 1 |
| Ciociola, AA; McSorley, DJ; Peterson, WL; Sykes, DL; Webb, DD | 1 |
| Webb, DD | 1 |
| Dixon, JS; Drake, FM; Tillman, LA; Wood, JR | 1 |
| Bardhan, KD; Buckley, MJ; De Koster, EH; Duggan, AE; Gilvarry, J; Gummett, PA; Logan, RP; O'Morain, CA; Pounder, RE; Rauws, EA; Schaufelberger, HD; Wyeth, JW | 1 |
| Davis, IM; Gooding, AE; Koch, KM; Yin, Y | 1 |
| Davis, IM; Gooding, AE; Kerr, BM; Koch, KM | 1 |
| Ciociola, AA; Heath, A; Walsh, JH; Webb, DD | 1 |
| Harris, A; Misiewicz, JJ | 1 |
| Axon, AT; Ireland, A; Rooprams, PD; Smith, MJ | 1 |
| Bye, A; Keene, ON; Lacey, LF; Pritchard, JF | 1 |
| Lambert, JR; Midolo, P | 1 |
| Pounder, RE; Williams, MP | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Bardhan, KD; Dallaire, C; Duggan, AE; Eisold, H | 1 |
| Bisso, G; Caroli, M; Celle, G; Mansi, C; Mela, GS; Mele, MR; Olivieri, A; Saggioro, A; Savarino, V; Termini, R; Tosatto, R; Vigneri, S | 1 |
| Hamilton, MR; Pounder, RE; Sercombe, JC; Williams, MP | 1 |
| Bennett, JE; Lacey, LF; Wakefield, JC | 1 |
| Cervantes Bustamante, R; Cuevas, S; Mata Rivera, N; Oyervides Garcia, I; Ramirez Mayans, JA; Zamora Davila, E; Zarate Mondragón, FE | 1 |
| Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
| Donnelly, C; McDowell, S; McLaren, A; Williamson, R | 1 |
| Bazzoli, F; Pozzato, P | 1 |
| Dixon, JS; Mills, JG; Pipkin, GA; Wood, JR | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lau, JY; Lee, YT; Leung, VK; Leung, WK; Ling, TK; Ng, EK; Suen, R; Sung, JJ | 1 |
| Fennerty, MB | 1 |
| Pipkin, GA; Williamson, R; Wood, JR | 2 |
| Bardhan, KD; Jahnsen, J; Lotay, N; Marcelino, M; Roberts, PM; Wurzer, H | 1 |
| Scheen, AJ | 1 |
| Canena, J; Leitão, J; Pinheiro, T; Pinto, AS; Quina, MG; Reis, J; Santos, AM | 1 |
| Vondracek, TG | 1 |
| Bardhan, KD; Blakemore, CB; Cary, BA; Hinchliffe, RF; Morris, P; Singh, S; Thompson, M; Wall, RM | 1 |
| Bazzoli, F; Cardelli, A; Catalano, FA; Giglio, A; Lami, F; Olivieri, A; Pilotto, A; Pozzato, P; Roda, E; Scarpulla, G; Spadaccini, A; Susi, D; Tosatto, R; Zagari, M | 1 |
| Crobach, LF; Geraedts, AA; Kolkman, JJ; Nicolai, JJ; Oudkerk Pool, M; Tan, TG; Timmerman, RJ; Van Der Laan, J; Van Kleef, WA; Wolff, AA | 1 |
| de Boer, WA; Haeck, PW; Mulder, CJ; Otten, MH | 1 |
| Bazzoli, F; Cannizzaro, O; D'Angelo, A; Ederle, A; Fossi, S; Gerace, G; Iaquinto, G; Olivieri, A; Pozzato, P; Reina, G; Ricciardiello, L; Roda, E; Scarpulla, G; Spadaccini, A; Tosatto, R; Zagari, M | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianei, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, A; Gasbarrini, G; Papa, A; Tursi, A | 1 |
| Carvalho, AF; Da Silva, CM; De Nucci, G; Ferraz, JG; Fiorelli, LA; Jorge, VN; Pedrazzoli, J | 1 |
| Bentivegna, C; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Condorelli, G | 1 |
| Di Matteo, G; Dobrilla, G; Dodero, M; Fina, P; Fratton, A; Iaquinto, G; Loriga, P; Marchi, S; Marzio, L; Muratori, R; Olivieri, A; Pacini, D; Saggioro, A; Savarino, V; Spinelli, P; Tosatto, R; Zamboni, G | 1 |
| Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; van der Wouden, EJ; van Zwet, AA | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Sung, JJ; Yung, MY | 1 |
| Ciociola, AA; Heath, A; Lanza, FL; McSorley, DJ; Sontag, SJ; Sykes, DL | 1 |
| Malfertheiner, P; Menegatti, M; Peitz, U; Vaira, D | 1 |
| Axon, AT | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Prieto, N; Sánchez, I | 1 |
| Howden, CW; Hunt, RH | 1 |
| Bardhan, KD; Duggan, AE; Gudjonsson, H; Hoie, O; Kliebe-Frisch, C; Kristensen, ES; Pipkin, GA; Schuetz, E | 1 |
| Bellin, EY; Fletcher, DD; Shuter, J; Simone, VJ | 1 |
| Barnett, J; Chey, WD; Delvalle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Palaniappan, J; Scheiman, J | 1 |
| Biagini, R; Bilardi, C; Bisso, G; Celle, G; Mansi, C; Mele, MR; Pivari, M; Savarino, V; Termini, R; Vigneri, S; Zentilin, P | 1 |
| Anti, M; Armuzzi, A; Bianchi Porro, G; Cammarota, G; Deltenre, M; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Malfertheiner, P; Mégraud, F; O'Morain, C; Pajares-García, J; Pretolani, S; Quina, M | 1 |
| Choi, CH; Kung, NN; Lai, WM; Lam, KN; Leung, EM; Li, TH; Lui, YH; Ng, PW; Sung, JJ; Yuen, NW | 1 |
| Kabala, A; Pawłowski, W; Petsch, B | 1 |
| Attili, AF; De Francesco, V; Faleo, D; Hassan, C; Rinaldi, V; Stoppino, V; Winn, S; Zullo, A | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Osato, MS; Qureshi, W | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; Van der Wouden, EJ; Zwet, AA | 1 |
| Fennerty, MB; Kelly, C; Knigge, K; Peterson, WL | 1 |
| Marshall, JB | 1 |
| Ashktorab, H; Hinds, T; Jagtap, J; Kim, KS; Scott, VF; Smoot, DT | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Prieto, N | 1 |
| Cave, DR; Hoffman, JS; Katz, LM | 1 |
| Bang, CJ; Berstad, A; Coll, P; Hatlebakk, JG; Hausken, T; Nysaeter, G; Olafsson, S; Olafsson, T; Tefera, S | 1 |
| Hirschowitz, BI; Mönkemüller, KE | 1 |
| Cutler, A; Vakil, N | 1 |
| Gisbert, JP; Pajares, JM; Valle, J | 1 |
| McSorley, DJ; Perschy, TB; Schwartz, HI; Sorrells, SC | 1 |
| Karim, QN; Sidebotham, RL; Worku, ML | 1 |
| Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
| Lichtenberger, LM; Ottlecz, A; Romero, JJ | 1 |
| Khan, F; Mason, J; Moshal, MG; Naidoo, V; Schlemmer, L; Spitaels, JM | 1 |
| Neiger, R; Schmassmann, A; Seiler, G | 1 |
| Bardhan, KD; Farley, A; French, PC; Paré, P; Roberts, PM; Romãozinho, JM | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Chippendale, GR; Garner, RM; Gilbert, JV; Kane, AV; Mobley, HL; Plaut, AG | 1 |
| Bravo, LE; Campo, C; Correa, P; Mera, R; Realpe, JL | 1 |
| Axon, A | 1 |
| Dagalp, K; Kadayifci, A; Kilinc, R; Uygun, A | 1 |
| Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM | 1 |
| Borda, F; Domínguez, E; Gisbert, JP; Sainz, R | 1 |
| Kerr, TG; Lambert, JR; Midolo, PD; Tee, W | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Papa, A; Pastorelli, A | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Gentiloni, N; Ojetti, V; Pastorelli, A; Pirozzi, G | 1 |
| Anti, M; Armuzzi, A; Branca, G; Candelli, M; Canducci, F; Fadda, G; Fedeli, G; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pastorelli, A; Pola, P; Torre, ES | 1 |
| Chan, FK; Chung, SC; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Chey, WD; Chien, NN; Chung, NQ; Connor, BA; Henley, KS; Hoan, PQ; Hop, TV; Lak, BV; Long, T; Mao, HV; Perez-Perez, GI; Stone, CD; Thang, DM | 1 |
| Ballardini, G; Boni, F; Bortoli, A; Colombo, E; Minoli, G; Spinzi, GC; Venturelli, R | 1 |
| Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG | 1 |
| Fox, JG; Marini, RP; McColm, AA; Taylor, NS; Williamson, R; Yan, L | 1 |
| Sung, JJ | 1 |
| Chmiela, M; Czkwianianc, E; Lawnik, M; Płaneta-Małecka, I; Rudnicka, W | 1 |
| Bilardi, C; Bisso, G; Borgonovo, G; Borro, P; De Salvo, L; Dulbecco, P; Mansi, C; Pivari, M; Raffaella Mele, M; Savarino, V; Tessieri, L; Vigneri, S; Zentilin, P | 1 |
| De Boer, WA; Jansen, JB; Van Oijen, AH; Verbeek, AL | 1 |
| Castellote, J; Porta, F | 1 |
| Calvet, X; Gabriel, R; Gisbert, JP; González, L; Pajares, JM; Roqué, M | 1 |
| Buzás György, M; Illyés, G; Székely, E; Széles, I | 1 |
| Thomson, AB | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R | 1 |
| Chiba, N | 1 |
| Blanco, M; Gisbert, JP; Pajares, JM | 1 |
| Akhunov, ED; Farztdinov, KM; Katayev, VA; Kazykhanov, NS; Khusnutdinov, SM; Nijevitch, AA; Sataev, VU | 1 |
| Cabezudo, JG; Ducóns, J; Gomollon, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
| Mégraud, F; Roberts, P; Williamson, R | 1 |
| Chan, CK; Chu, KM; Fung, FM; Hu, WH; Lai, KC; Lam, SK; Lau, GK; Leung, SY; Wang, WH; Wong, BC; Wong, WM; Yuen, MF; Yuen, ST | 1 |
| Dashkova, S; Farztdinov, KM; Kazykhanov, NS; Nijevitch, AA; Sataev, VU | 1 |
| De Boer, WA; Jansen, JB; Janssen, MJ; Van Oijen, AH; Verbeek, AL | 1 |
| Kearney, DJ | 1 |
| Chejfec, G; O'Connell, S; Schnell, T; Seidel, J; Sonnenberg, A; Sontag, SJ | 1 |
| Belmonte, A; Cavaliere, C; Ciliberto, E; Fiocca, R; Frandina, C; Giglio, A; Luzza, F; Pallone, F; Saccà, N; Trimboli, V | 1 |
| Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Hopkins, RJ | 1 |
| Dixon, CA; Hopkins, RJ; Meyer, JM; Siepman, NY; Silliman, NP; Sugg, JE | 1 |
| Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 2 |
| Chiba, N; Hunt, RH; Thomson, AB | 1 |
| Campo, SM; De Matthaeis, M; Febbraro, I; Hassan, C; Lorenzetti, R; Morini, S; Porto, D; Zullo, A | 1 |
| Bardhan, KD; Mitchell, TR; Morris, P; Morton, D; Perry, MJ; Roberts, PM; Rowland, A; Sanders, DS; Thompson, M | 1 |
| Ananthakrishnan, N; Badrinath, S; Kate, V | 1 |
| Amini, M; Kamalian, N; Kaviani, MJ; Malekzadeh, R; Massarrat, S; Sotoudeh, M; Vahedi, H | 1 |
| Bujanda, L; Cosme, A; Iriondo, C; Muñoz, C; Sánchez, A; Santos, A | 1 |
| Beales, IL | 1 |
| Doulgeroglou, V; Kamberoglou, D; Patra, E; Polymeros, D; Sanidas, I; Savva, S; Tzias, V | 1 |
| Dudik, TV; Il'chenko, AA; Kaprel'yants, AS; Loginov, AS; Reshetnyak, VI; Vostroknutova, GN | 1 |
| Corder, FA; Howden, CW; Sahai, AV; Sharma, VK | 1 |
| Fang, XC; Hu, PJ; Li, ZS; Lu, H; Lu, XH; Xiao, SD; Zhang, DZ | 1 |
| De Francesco, V; Faleo, D; Hassan, C; Ierardi, E; Morini, S; Panella, C; Zullo, A | 1 |
| Markova, T; Schwartz, K | 1 |
| Andriulli, A; Clemente, R; Festa, V; Merla, A; Perri, F; Quitadamo, M | 1 |
| Gisbert, JP; Pajares, JM | 1 |
| Brorson, O; Brorson, SH | 1 |
| Gómez Rodríguez, B; Hergueta Delgado, P; Herrerías Gutiérrez, JM; Mendoza Olivares, FJ; Pellicer Bautista, FJ; Rojas Feria, M; Romero Castro, R | 1 |
| Cuena Boy, R | 1 |
| Michetti, P; Suerbaum, S | 1 |
| Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M | 1 |
| Chan, CK; Fung, FM; Ho, VY; Hu, WH; Hung, WK; Lai, KC; Lam, SK; Szeto, ML; Tong, TS; Wong, BC; Wong, GS; Wong, WM; Xia, HH; Yip, AW; Yuen, MF | 1 |
| Kullavanijaya, P; Tangkijvanich, P; Thong-Ngam, D; Treeprasertsuk, S; Wisedopas, N | 1 |
| Farup, PG; Høie, O; Lange, OJ; Tholfsen, J; Torp, R; Wetternus, S | 1 |
| Berstad, A; Hatlebakk, JG; Olafsson, S | 1 |
| Hopkins, RJ; Meyer, JM | 1 |
| Chehter, EZ; Eisig, JN; Hashimoto, C; Laudanna, AA; Silva, FM | 1 |
| Danscher, G; Larsen, A; Martiny, N; Rungby, J; Stoltenberg, M | 1 |
| Barkun, A; Chiba, N; Cockeram, A; Dallaire, C; Fallone, C; Farley, A; Nicholls, B; Simms, L; Veldhuyzen van Zanten, S | 1 |
| Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
| Balatsinou, C; Caldarella, MP; Cuccurullo, F; Di Bonaventura, G; Lapenna, D; Laterza, F; Milano, A; Neri, M; Piccolomini, R | 1 |
| Bianchi Porro, G; Cucino, C; Parente, F | 1 |
| Candelli, M; Franceschi, F; Gasbarrini, G; Mettimano, M; Migneco, A; Montebelli, R; Ojetti, V; Savi, L; Specchia, L | 1 |
| de Boer, WA; Kuipers, EJ; Kusters, JG | 1 |
| Altintaş, E; Aydin, O; Camdeviren, H; Sezgin, O; Ulu, O | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Panella, C; Vaira, D; Zullo, A | 1 |
| Candelli, M; Carloni, E; Cazzato, A; Di Campli, C; Fini, L; Gasbarrini, A; Gasbarrini, G; Nista, EC; Pignataro, G; Zocco, MA | 1 |
| Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF | 1 |
| Calvet, X; Carpio, D; Fuentes, J; Gisbert, JP; Guardiola, J; Olivares, D; Tito, L; Tomas, A | 1 |
| Huang, JQ; Hunt, RH; Karlberg, J; Lam, SK; Wong, BC; Wong, WM; Zheng, GF | 1 |
| Calvet, X; Gisbert, JP; Gonzalez, L | 1 |
| Almeida, JR; Campos, LT; Guerrazzi, F; Lorena, SL; Mesquita, MA; Montes, CG; Zeitune, JM | 1 |
| Donovan, JL; Egger, M; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P; Noble, S | 1 |
| Akarca, US; Aydin, A; Musoğlu, A; Onder, GF; Tekin, F; Tunçyürek, M | 1 |
| Lule, GN | 1 |
| Jiang, B; Ruan, ZR; Xu, DH; Yuan, H; Zhou, Q | 1 |
| Lee, KH; Tam, YH; Yeung, CK | 1 |
| Altintaş, E; Sezgin, O; Tataroğlu, C; Uçbilek, E | 1 |
| Ge, R; He, QY; Huang, JD; Sun, H; Sun, X; Watt, RM; Wilcox, DE; Zhang, Y | 1 |
| Buzás, GM; Józan, J | 2 |
| Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pajares, JM | 1 |
| Aiello, F; Brandimarte, G; Elisei, W; Giorgetti, GM; Modeo, ME; Tursi, A | 1 |
| Fernández-Bermejo, M; Gisbert, JP; González-García, G; Mateos-Rodríguez, JM; Molina-Infante, J; Pérez-Gallardo, B; Prieto-Bermejo, AB; Robledo-Andrés, P | 1 |
| Mahachai, V; Thong-Ngam, D | 1 |
| Buzás, GM; Széles, I | 1 |
| Cakal, B; Kiliç, ZM; Köksal, AS; Kuran, S; Nadir, I; Ozin, YO; Sahin, B | 1 |
| Ran, ZH; Shen, J; Tong, JL; Xiao, SD | 1 |
| Akay, S; Akyildiz, M; Aydin, A; Musoglu, A; Tuncyurek, M | 1 |
| Huang, JD; Sun, HZ; Tanner, JA; Watt, RM | 1 |
| Amini, M; Tajik, A | 1 |
| Demir, M; Gokturk, HS; Ozturk, NA; Serin, E; Yilmaz, U | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H | 1 |
| Apikoglu-Rabus, S; Cevikbas, U; Izzettin, FV; Okuyan, B; Sancar, M | 1 |
| Astegiano, M; Cisarò, F; De Angelis, C; Pellicano, R; Rizzetto, M; Saracco, G | 1 |
| Agarwal, A; Agrawal, GP; Agrawal, H; Jain, AK | 1 |
| Ateş, Y; Avşar, E; Aytuğ, N; Bektaş, A; Bölükbaş, C; Dinçer, D; Ellidokuz, E; Erzin, Y; Güliter, S; Kaymakoğlu, S; Kocakaya, O; Onuk, MD; Poturoğlu, S; Taşan, G; Tiftikçi, A; Türkay, C; Yıldırım, B; Yılmaz, U | 1 |
| Balderas-López, JL; Bernad-Bernad, MJ; Medina-Torres, L; Navarrete, A; Orona-Ortiz, A; Pineda-Peña, EA; Tavares Carvalho, JC; Velázquez-Moyado, JA | 1 |
| Chan, JF; Cheng, T; Chik, KK; Jin, DY; Jin, L; Lee, AC; Li, H; Sun, H; Wang, R; Wang, S; Ye, ZW; Yuan, S; Yuen, KY; Zhang, AJ | 1 |
| Cha, JM; Jeon, JW; Kwak, MS; Yoon, JY | 1 |
42 review(s) available for bismuth and ranitidine
| Article | Year |
|---|---|
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Half-Life; Humans; Kinetics; Organometallic Compounds; Peptic Ulcer; Ranitidine; Smoking | 1988 |
The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
Topics: Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Ranitidine | 1986 |
Medical treatment of peptic ulcers.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Cimetidine; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins; Ranitidine; Recurrence; Sucralfate; Zollinger-Ellison Syndrome | 1985 |
Update in treatment of peptic ulcer disease.
Topics: Adult; Aged; Alcohol Drinking; Aluminum; Antacids; Anti-Ulcer Agents; Aspirin; Bismuth; Cimetidine; Female; Humans; Male; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence; Smoking; Sucralfate; Vagotomy, Proximal Gastric | 1984 |
Medical management of peptic ulcer.
Topics: Aluminum; Antacids; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Parasympatholytics; Ranitidine; Recurrence; Stomach Ulcer; Sucralfate; Time Factors | 1984 |
Pharmacologic options for the control of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins, Synthetic; Ranitidine; Risk; Stomach Neoplasms; Surface-Active Agents | 1984 |
[Status of ranitidine in eradication of Helicobacter pylori].
Topics: Amoxicillin; Bismuth; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine | 1995 |
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Ranitidine; Salicylates; Stomach; Stomach Neoplasms | 1994 |
Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Controlled Clinical Trials as Topic; Famotidine; Histamine H2 Antagonists; Humans; Placebos; Ranitidine; Stomach Ulcer; Sucralfate; Time Factors | 1996 |
[How to eradicate Helicobacter pylori in 1995? Critical review of available treatments].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Omeprazole; Penicillins; Ranitidine | 1996 |
Review article: safety of bismuth in the treatment of gastrointestinal diseases.
Topics: Bismuth; Dyspepsia; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Peptic Ulcer; Ranitidine | 1996 |
The actions of bismuth in the treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Drug Synergism; Duodenum; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Organometallic Compounds; Ranitidine; Salicylates; Treatment Outcome | 1997 |
The treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma; Proton Pump Inhibitors; Ranitidine; Risk Factors; Stomach Neoplasms | 1997 |
New developments in Helicobacter pylori eradication therapy.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1997 |
Therapy of H. pylori infection.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine; Tinidazole | 1997 |
Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1997 |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1998 |
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Interactions; Duodenal Ulcer; Formularies as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine | 1998 |
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine | 1998 |
Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Azithromycin; Bismuth; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine | 1998 |
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Neoplasms; Endoscopy, Digestive System; Enzyme Inhibitors; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Organometallic Compounds; Peptic Ulcer; Practice Guidelines as Topic; Proton Pump Inhibitors; Ranitidine; Stomach Neoplasms | 1998 |
Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Pilot Projects; Ranitidine; Treatment Outcome | 1999 |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Duodenitis; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lymphoma, B-Cell, Marginal Zone; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Ranitidine; Stomach Neoplasms; Stomach Ulcer | 1999 |
Where are We with current therapy?
Topics: Adult; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine | 2000 |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 2000 |
Therapy for H. pylori infection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine; Stomach Diseases | 1999 |
Retreatment of Helicobacter pylori infection after initial treatment failure.
Topics: Anti-Ulcer Agents; Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine; Retreatment; Treatment Failure | 2001 |
Helicobacter pylori and early duodenal ulcer status post-treatment: a review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Odds Ratio; Omeprazole; Ranitidine; Research Design; Retrospective Studies; United States; United States Food and Drug Administration | 2001 |
Ranitidine bismuth citrate.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine | 2001 |
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; MEDLINE; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Risk Factors; Salicylates; Sensitivity and Specificity | 2001 |
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Histamine H2 Antagonists; Humans; Metronidazole; Patient Care Planning; Penicillins; Proton Pumps; Ranitidine; Recurrence | 2002 |
Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Proton Pump Inhibitors; Ranitidine; Salicylates; Virulence | 2002 |
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine | 2003 |
Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline | 2004 |
Treatment of H. pylori infection: a review.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Clarithromycin; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Ofloxacin; Polypharmacy; Ranitidine; Rifabutin | 2005 |
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2005 |
Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 2005 |
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004.
Topics: Anti-Infective Agents; Bismuth; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pumps; Ranitidine; Time Factors; Treatment Outcome | 2006 |
Nitrofuran-based regimens for the eradication of Helicobacter pylori infection.
Topics: Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Proton Pump Inhibitors; Ranitidine | 2007 |
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tinidazole; Treatment Outcome | 2009 |
Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2010 |
134 trial(s) available for bismuth and ranitidine
| Article | Year |
|---|---|
Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
Topics: Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Time Factors | 1992 |
Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Bismuth; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Ranitidine; Recurrence; Regression Analysis; Water | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Risk Factors; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
Enteric-coated charcoal as a means of blinding studies comparing bismuth and H2-receptor antagonists.
Topics: Administration, Oral; Adult; Bismuth; Charcoal; Color; Double-Blind Method; Drug Therapy, Combination; Feces; Female; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Reference Values; Tablets, Enteric-Coated | 1992 |
The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity.
Topics: Adolescent; Adult; Bismuth; Circadian Rhythm; Citrates; Double-Blind Method; Gastric Acid; Histamine H2 Antagonists; Humans; Male; Ranitidine | 1991 |
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Single-Blind Method; Tetracycline | 1991 |
The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Humans; Intestinal Absorption; Male; Organometallic Compounds; Placebos; Ranitidine; Receptors, Histamine H2; Salicylates | 1991 |
Medical treatment of antral gastrin cell hyperfunction: role of nonantisecretory therapy.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Bismuth; Cimetidine; Duodenal Ulcer; Enterochromaffin Cells; Female; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine | 1990 |
[Epidemiology and therapy of Campylobacter pylori infection].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Drug Evaluation; Drug Therapy, Combination; Duodenum; Female; Gastrointestinal Diseases; Gastroscopy; Germany, West; Humans; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Stomach | 1989 |
Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.
Topics: Adult; Aged; Antacids; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Female; Gastrins; Humans; Male; Middle Aged; Organometallic Compounds; Patient Compliance; Pepsinogens; Random Allocation; Ranitidine; Recurrence; Smoking; Tablets | 1985 |
Does Caved-S decrease the gastric ulcer relapse rate during maintenance treatment with ranitidine?
Topics: Adult; Aluminum Hydroxide; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Glycyrrhiza; Humans; Magnesium Hydroxide; Male; Middle Aged; Plant Extracts; Ranitidine; Recurrence; Sodium Bicarbonate; Stomach Ulcer | 1987 |
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Clinical Trials as Topic; Half-Life; Humans; Kinetics; Organometallic Compounds; Peptic Ulcer; Ranitidine; Smoking | 1988 |
Colloidal bismuth subcitrate and ranitidine in the short-term treatment of benign gastric ulcer. An endoscopically controlled trial.
Topics: Adult; Bismuth; Female; Gastroscopy; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Ranitidine; Stomach Ulcer | 1986 |
A comparison of colloidal bismuth subcitrate tablets and ranitidine in the treatment of chronic duodenal ulcers.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Chronic Disease; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Ranitidine | 1986 |
The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
Topics: Bismuth; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Humans; Organometallic Compounds; Ranitidine | 1986 |
Comparison between ranitidine and ranitidine plus Caved-S in the treatment of gastric ulceration.
Topics: Aged; Aluminum Hydroxide; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Dyspepsia; Female; Glycyrrhiza; Humans; Magnesium Hydroxide; Male; Middle Aged; Plant Extracts; Ranitidine; Sodium Bicarbonate; Stomach Ulcer | 1985 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
Healing of gastric body ulcer with gastroprotective versus antisecretory treatment.
Topics: Adult; Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organometallic Compounds; Ranitidine; Recurrence; Stomach Ulcer; Time Factors | 1995 |
Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers.
Topics: Adult; Bismuth; Breath Tests; Carbon Radioisotopes; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Food; Headache; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Incidence; Male; Ranitidine; Time Factors; Urea | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
Topics: Adolescent; Adult; Anti-Ulcer Agents; Bismuth; Citrates; Double-Blind Method; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine | 1994 |
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
Topics: Azithromycin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal.
Topics: Adult; Bismuth; Citrates; Cross-Over Studies; Double-Blind Method; Food, Formulated; Gastric Emptying; Histamine H2 Antagonists; Humans; Male; Ranitidine; Technetium Tc 99m Pentetate | 1994 |
Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury.
Topics: Adult; Aspirin; Bismuth; Citrates; Double-Blind Method; Duodenum; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Ranitidine | 1993 |
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Topics: Adult; Aged; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline | 1993 |
Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.
Topics: Adult; Aged; Bismuth; Breath Tests; Citrates; Duodenal Ulcer; Food; Gastrins; Humans; Male; Middle Aged; Organometallic Compounds; Pepsinogens; Ranitidine; Time Factors | 1993 |
Gastric persorption of bismuth from ranitidine bismuth citrate.
Topics: Adult; Bismuth; Dyspepsia; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Male; Microscopy, Electron; Ranitidine | 1995 |
GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer.
Topics: Adult; Bismuth; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Logistic Models; Male; Middle Aged; Ranitidine; Treatment Outcome | 1995 |
Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Palliative Care; Peptic Ulcer; Ranitidine; Treatment Outcome | 1996 |
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine; Recurrence | 1996 |
The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine | 1996 |
Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
Topics: Adult; Area Under Curve; Bismuth; Half-Life; Histamine H2 Antagonists; Humans; Male; Metabolic Clearance Rate; Ranitidine | 1996 |
Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
Topics: Adult; Area Under Curve; Bismuth; Half-Life; Histamine H2 Antagonists; Humans; Male; Metabolic Clearance Rate; Middle Aged; Ranitidine | 1996 |
Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
Topics: Administration, Oral; Adolescent; Adult; Antacids; Bismuth; Dose-Response Relationship, Drug; Double-Blind Method; Food; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Peptones; Placebos; Ranitidine; Stimulation, Chemical | 1996 |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Ranitidine; Treatment Outcome; Wound Healing | 1997 |
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Pyloric Antrum; Ranitidine | 1997 |
Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tetracycline | 1997 |
[Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
Topics: Abdominal Pain; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Longitudinal Studies; Male; Prospective Studies; Ranitidine; Recurrence | 1996 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer Hemorrhage; Ranitidine; Recurrence; Tetracycline | 1997 |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline | 1998 |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 1998 |
Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence | 1997 |
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine | 1998 |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing | 1997 |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Stomach Ulcer; Tetracycline; Treatment Outcome | 1998 |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole | 1998 |
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole | 1998 |
Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Ranitidine; Stomach Ulcer | 1998 |
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 1998 |
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine | 1998 |
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase; Ranitidine | 1998 |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Time Factors; Treatment Failure | 1998 |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pumps; Ranitidine; Single-Blind Method; Treatment Outcome | 1998 |
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Recurrence; Treatment Outcome | 1998 |
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 1998 |
Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Azithromycin; Bismuth; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine | 1998 |
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome; Urea | 1999 |
One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Tetracycline | 1999 |
[The treatment of chronic duodenal ulcer with accompanying Helicobacter pylori infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clinical Protocols; Duodenal Ulcer; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Retrospective Studies; Treatment Outcome | 1998 |
Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy.
Topics: Adolescent; Adult; Aged; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Proton Pump Inhibitors; Ranitidine | 1999 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Ranitidine; Stomach Ulcer | 1999 |
Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Compliance; Ranitidine; Tetracycline; Urea | 1999 |
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
Topics: Adult; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Ranitidine; Time Factors | 1999 |
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 1999 |
Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Prospective Studies; Ranitidine; Spiramycin | 1999 |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Penicillins; Ranitidine; Urea | 1999 |
Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ranitidine | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
Factors affecting duodenal ulcer healing. Four double-blind trials in 193 patients.
Topics: Adult; Alcohol Drinking; Anti-Ulcer Agents; Bismuth; Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Metalloproteins; Placebos; Proteins; Ranitidine; Smoking; Sucralfate | 1982 |
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Ranitidine | 1999 |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 1999 |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine; Turkey | 1999 |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 1999 |
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tinidazole; Treatment Outcome; Urea | 1999 |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Prospective Studies; Ranitidine; Tinidazole; Urea | 2000 |
Efficacy of a multistep strategy for Helicobacter pylori eradication.
Topics: Algorithms; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole; Treatment Failure | 2000 |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Salvage Therapy | 2000 |
Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Bismuth; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A; Male; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Urease; Vietnam | 2000 |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 2000 |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Tinidazole | 2000 |
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Helicobacter; Helicobacter Infections; Ovariectomy; Ranitidine; Time Factors | 1999 |
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 2000 |
[Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Time Factors | 2000 |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2000 |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
[Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa. An 18-month follow-up study].
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Severity of Illness Index; Treatment Outcome | 2000 |
Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Ranitidine; Tinidazole | 2000 |
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Synergism; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine | 2000 |
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Ranitidine; Treatment Outcome; Urea | 2001 |
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Penicillins; Ranitidine; Veterans | 2001 |
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pruritus; Ranitidine; Recurrence; Taste Disorders; Tinidazole; Treatment Outcome | 2001 |
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea | 2001 |
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 2001 |
A triple therapy regimen after failed Helicobacter pylori treatments.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Tetracycline; Tinidazole; Urea; Urease | 2001 |
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome; Urea; Urease | 2001 |
Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer Perforation; Prospective Studies; Ranitidine; Recurrence; Retrospective Studies; Tetracycline | 2001 |
Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Bismuth; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esophagoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Urea | 2001 |
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 2001 |
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 2001 |
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Retrospective Studies | 2001 |
One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Diarrhea; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exanthema; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Prospective Studies; Pruritus; Ranitidine; Tetracycline; Treatment Outcome; Vomiting | 2001 |
Two new treatment regimens for Helicobacter pylori eradication: a randomised study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 2001 |
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 2002 |
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection.
Topics: Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine | 2002 |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2002 |
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Treatment Outcome | 2002 |
Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Stomach; Thailand; Treatment Outcome | 2002 |
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Tetracycline | 2002 |
Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenitis; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Peptic Ulcer; Ranitidine; Spiramycin; Time Factors | 2002 |
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Ranitidine; Time Factors; Urea | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Tinidazole; Treatment Outcome | 2003 |
Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Bismuth; Blood Pressure; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Male; Middle Aged; Prevalence; Ranitidine | 2003 |
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Azithromycin; Bismuth; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey | 2005 |
7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 2005 |
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome | 2005 |
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Patient Acceptance of Health Care; Peptic Ulcer; Quality of Life; Ranitidine | 2006 |
Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.
Topics: Adolescent; Adult; Analysis of Variance; Antacids; Biological Availability; Bismuth; Chromatography, High Pressure Liquid; Cross-Over Studies; Histamine H2 Antagonists; Humans; Male; Ranitidine; Reproducibility of Results; Spectrophotometry, Atomic; Therapeutic Equivalency; Time Factors | 2006 |
Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Prospective Studies; Ranitidine | 2006 |
Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Ranitidine; Tetracycline; Treatment Outcome; Urease; Young Adult | 2006 |
Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Ranitidine; Treatment Failure; Treatment Outcome | 2007 |
Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole | 2007 |
First-line triple therapy with levofloxacin for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Ranitidine; Treatment Outcome | 2007 |
Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Urea | 2008 |
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Humans; Male; Middle Aged; Moxifloxacin; Pilot Projects; Prospective Studies; Quinolines; Ranitidine; Treatment Outcome; Young Adult | 2008 |
The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Tetracyclines; Treatment Outcome | 2009 |
Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Ranitidine | 2009 |
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome; Young Adult | 2013 |
Pretreatment with Ranitidine Bismuth Citrate May Improve Success Rates of Helicobacter pylori Eradication: A Prospective, Randomized, Controlled and Open-Label Study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Treatment Failure; Treatment Outcome | 2021 |
70 other study(ies) available for bismuth and ranitidine
| Article | Year |
|---|---|
Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
Topics: Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence; Salicylates; Tetracycline | 1992 |
[Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Salicylates | 1989 |
Acid rules--or does it?
Topics: Anti-Ulcer Agents; Bismuth; Gastric Acid; Histamine H2 Antagonists; Humans; Organometallic Compounds; Peptic Ulcer; Ranitidine; Sucralfate | 1986 |
[Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
Topics: Adult; Aged; Bismuth; Drug Evaluation; Drug Tolerance; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Stomach Ulcer | 1984 |
Problems associated with medical treatment of peptic ulcer disease.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Antidepressive Agents, Tricyclic; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Colloids; Female; Humans; Male; Parasympatholytics; Peptic Ulcer; Prostaglandins; Ranitidine; Sucralfate | 1984 |
Another look at peptic ulcer.
Topics: Antacids; Bismuth; Chronic Disease; Cimetidine; Colloids; Duodenal Ulcer; Female; Furans; Histamine H2 Antagonists; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Stomach Ulcer | 1981 |
[Innovations in the treatment of gastroduodenal ulcers].
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzodiazepinones; Bismuth; Cimetidine; Furans; Humans; Organometallic Compounds; Peptic Ulcer; Pirenzepine; Placebos; Prostaglandins; Ranitidine; Sucralfate | 1983 |
Duodenal ulcers that will not heal.
Topics: Anti-Ulcer Agents; Benzimidazoles; Bismuth; Cimetidine; Drug Resistance; Duodenal Ulcer; Humans; Omeprazole; Organometallic Compounds; Ranitidine | 1984 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline; Time Factors | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Administration, Oral; Adult; Aged; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Tetracycline | 1993 |
Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Citrates; Dogs; Ethanol; Female; Ferrets; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Indomethacin; Isoenzymes; Male; Microbial Sensitivity Tests; Organometallic Compounds; Pepsin A; Ranitidine; Rats; Stomach Ulcer | 1993 |
[Costs and effectiveness of diagnosis and treatment of patients with dyspepsia, determined with the aid of a computer model].
Topics: Bismuth; Cimetidine; Clinical Protocols; Computer Simulation; Cost-Benefit Analysis; Drug Therapy, Combination; Dyspepsia; Humans; Ranitidine | 1993 |
Esophagitis and Helicobacter pylori in children: incidence and therapeutic implications.
Topics: Adolescent; Amoxicillin; Bismuth; Child; Cimetidine; Esophagitis; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Pyloric Antrum; Ranitidine | 1993 |
Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine; Recurrence; Time Factors | 1996 |
Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Drug Combinations; Female; Gastric Acid; Helicobacter pylori; Histamine H2 Antagonists; Humans; Isoenzymes; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred ICR; Organometallic Compounds; Pepsin A; Ranitidine; Solubility; Spectrophotometry, Infrared; X-Ray Diffraction | 1996 |
Practice guidelines for treatment of peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine | 1996 |
Pylorid, H. pylori and peptic ulcer.
Topics: Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Randomized Controlled Trials as Topic; Ranitidine | 1996 |
Ranitidine bismuth citrate therapy.
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 1996 |
Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed?
Topics: Bismuth; Body Fluid Compartments; Data Interpretation, Statistical; Humans; Normal Distribution; Ondansetron; Pharmacokinetics; Randomized Controlled Trials as Topic; Ranitidine; Sumatriptan | 1997 |
Modeling of trough plasma bismuth concentrations.
Topics: Bayes Theorem; Bismuth; Histamine H2 Antagonists; Humans; Male; Models, Biological; Ranitidine | 1997 |
The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Microbial; Helicobacter pylori; Histamine H2 Antagonists; Metronidazole; Ranitidine; Streptomycin | 1997 |
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Receptors, Histamine H2; Stomach Ulcer | 1998 |
Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Bismuth; Brain; Histamine H2 Antagonists; Kidney; Liver; Lung; Male; Organometallic Compounds; Ranitidine; Rats; Rats, Wistar | 1998 |
The European meeting on Helicobacter pylori: therapeutic news from Lisbon.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Portugal; Proton Pump Inhibitors; Ranitidine | 1998 |
Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bacterial Vaccines; Bismuth; Drug Design; Drug Therapy, Combination; Duodenitis; Forecasting; Gastritis; Genome, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine | 1998 |
Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.
Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Microbial; Drug Synergism; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Ranitidine | 1998 |
Treating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine | 1998 |
The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; New York City; Organometallic Compounds; Peptic Ulcer; Prisons; Ranitidine; Retrospective Studies; Salicylates; Tetracycline; Urban Health | 1998 |
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tetracycline | 1999 |
Duodenal ulcer disease: to treat H. pylori infection or not?
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ranitidine; Tetracycline; United States | 1992 |
Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
Topics: Anti-Ulcer Agents; Bismuth; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Ranitidine | 1999 |
Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Ranitidine; Tetracycline | 1999 |
Effects of ranitidine bismuth citrate on Helicobacter pylori motility, morphology and survival.
Topics: Anti-Ulcer Agents; Bismuth; Helicobacter pylori; Humans; Microscopy, Electron; Organometallic Compounds; Ranitidine | 1999 |
Effect of ranitidine bismuth citrate on the phospholipase A2 activity of Naja naja venom and Helicobacter pylori: a biochemical analysis.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Elapid Venoms; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Phospholipases A; Phospholipases A2; Ranitidine | 1999 |
Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii.
Topics: Animals; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Azithromycin; Biopsy; Bismuth; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Cat Diseases; Cats; Clarithromycin; Female; Gas Chromatography-Mass Spectrometry; Helicobacter; Helicobacter Infections; Male; Metronidazole; Polymerase Chain Reaction; Prospective Studies; Random Allocation; Ranitidine; Stomach Diseases; Tinidazole; Urea | 1999 |
Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions.
Topics: Bacterial Proteins; Bismuth; Carrier Proteins; Cation Transport Proteins; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Membrane Proteins; Metals, Heavy; Microbial Sensitivity Tests; Organometallic Compounds; Proteins; Ranitidine | 1999 |
Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antigens, Bacterial; Bismuth; Breath Tests; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Sensitivity and Specificity; Urea | 1999 |
Treatment of Helicobacter pylori: where are we now? What are the key questions?
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Treatment Outcome; United Kingdom | 1999 |
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Ranitidine; Tetracycline | 1999 |
[IgG and IgA immunoglobulins in helicobacter pylori infections of children with chronic dyspepsia before and after two week triple drug therapy].
Topics: Adolescent; Amoxicillin; Bismuth; Blotting, Western; Child; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Monitoring, Physiologic; Ranitidine; Serologic Tests | 1999 |
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Ranitidine; Salicylates | 2000 |
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Ranitidine | 2001 |
Optimal strategy of treatment of Helicobacter pylori infection: renaissance of antisecretory drugs?
Topics: Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine | 2001 |
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Patient Care Planning; Penicillins; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Treatment Outcome | 2001 |
In search of the Holy Grail of Heliocobacter pylori remedies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Humans; Metronidazole; Pilot Projects; Ranitidine; Spain | 2001 |
Efficacy of Helicobacter pylori eradication therapies: a single centre observational study.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Ranitidine; Treatment Outcome | 2001 |
Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Bismuth; DNA Fingerprinting; Duodenal Ulcer; Female; Flagellin; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Ranitidine; Recurrence; Restriction Mapping; Species Specificity; Time Factors; Urease | 2001 |
What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt?
Topics: Adult; Anti-Bacterial Agents; Bismuth; Drug Costs; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Analysis as Topic; Proton Pump Inhibitors; Ranitidine | 2002 |
Susceptibility of motile and cystic forms of Borrelia burgdorferi to ranitidine bismuth citrate.
Topics: Anti-Bacterial Agents; Bismuth; Borrelia burgdorferi; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Movement; Ranitidine; Time Factors | 2001 |
[Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine | 2002 |
Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine | 2003 |
Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine | 2003 |
Gastrointestinal and systemic uptake of bismuth in mice after oral exposure.
Topics: Absorption; Administration, Oral; Animals; Bismuth; Dose-Response Relationship, Drug; Female; Intestinal Absorption; Kidney; Liver; Lysosomes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microscopy, Electron; Organometallic Compounds; Ranitidine; Staining and Labeling; Time Factors | 2003 |
Information from your family doctor. Ulcers and Helicobacter pylori infection.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Family Practice; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine | 2003 |
Sequential therapy for H. pylori: an 'aberrant' therapy ready for general use.
Topics: Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine | 2004 |
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymerase Chain Reaction; Ranitidine; Treatment Outcome | 2005 |
Helicobacter pylori eradication in peptic dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2005 |
Thermodynamic and kinetic aspects of metal binding to the histidine-rich protein, Hpn.
Topics: Amino Acid Sequence; Bacterial Proteins; Binding, Competitive; Bismuth; Copper Sulfate; Edetic Acid; Escherichia coli; Hydrogen-Ion Concentration; Kinetics; Metals; Molecular Sequence Data; Nickel; Protein Binding; Proteins; Ranitidine; Thermodynamics; Zinc Sulfate | 2006 |
14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Ranitidine; Tetracycline; Treatment Failure | 2006 |
Determination of the functions of the putative metal-binding domain of the SCV helicase.
Topics: Antiviral Agents; Binding Sites; Bismuth; DNA Helicases; Ranitidine; Severe acute respiratory syndrome-related coronavirus; Zinc | 2009 |
Oral and intravenous eradication of Helicobacter pylori.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Pilot Projects; Ranitidine; Treatment Outcome | 2009 |
Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Hematologic Tests; Indomethacin; Male; Misoprostol; Omeprazole; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer | 2012 |
Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2011 |
Double-liposome-based dual-drug delivery system as vectors for effective management of peptic ulcer.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Stability; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Liposomes; Male; Microbial Sensitivity Tests; Particle Size; Peptic Ulcer; Ranitidine; Rats | 2012 |
Mucoadhesive effect of Curcuma longa extract and curcumin decreases the ranitidine effect, but not bismuth subsalicylate on ethanol-induced ulcer model.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Curcuma; Curcumin; Disease Models, Animal; Drug Interactions; Ethanol; Gastric Mucosa; Herb-Drug Interactions; Male; Organometallic Compounds; Plant Extracts; Ranitidine; Rats; Rats, Wistar; Salicylates; Stomach Ulcer | 2019 |
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.
Topics: Animals; Antiviral Agents; Betacoronavirus; Bismuth; Chemokines; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Disease Models, Animal; HEK293 Cells; Humans; Lung; Mesocricetus; Pandemics; Pneumonia, Viral; Ranitidine; RNA Helicases; SARS-CoV-2; Vero Cells; Viral Load; Virus Replication | 2020 |